Delivery Order SPE2DB22D3301-SPE2DB25FX3GS
Award Date
10/7/24
Potential Completion Date
10/8/24
Potential Value
$6.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order from the Defense Logistics Agency (DLA) awarded to AmerisourceBergen Drug Corporation Corporate Office Division, a major pharmaceutical distributor. The $6,677.64 firm-fixed-price contract is for the supply of XELJANZ XR 11 MG TABLET, a prescription medication. The contract has an ultimate completion date of August 19, 2024. AmerisourceBergen has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and other federal agencies, valued at up to $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of XELJANZ XR 11 MG TABLET. The fixed-price delivery order, valued at $39,710.32, has a completion date of September 6, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these prescription medications to support DLA's medical supply requirements. This order is issued under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop...
This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) Troop Support to AmerisourceBergen Drug Corp's Corporate Office division. The $4,377.27 firm-fixed-price contract is for the delivery of XELJANZ XR 11 MG TABLET, a prescription medication. The contract has an ultimate completion date of August 21, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the United States, has been awarded numerous federal contracts to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,757.10, is for the delivery of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product. The contract is a firm fixed price delivery order, with a period of performance through May 12, 2025. This contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a...
This is a $9,937.42 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product, with a performance period through April 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract, valued at $6,969.24, is for the supply of the pharmaceutical product XELJANZ XR 11 MG TABLET UU 30S. The award has an ultimate completion date of August 22, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $42,194.36 firm fixed-price contract is for the delivery of XELJANZ XR 11 MG TABLET UU 30S, a prescription medication. The contract has an ultimate completion date of April 9, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product, with a ceiling value of $3,118.90 and a performance period ending on May 15, 2025. The contract is a Firm Fixed Price, non-set-aside award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of XELJANZ XR 11 MG TABLET UU 30S. The award is not set aside and has a firm fixed price of $9,689.69. The ultimate completion date for this contract is October 11, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with various federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product, with a ceiling value of $3,198.50. The contract is a firm-fixed-price delivery order with a period of performance through June 12, 2025. This award is not set aside for any special business category. AmerisourceBergen Drug...